EBS 经营现金流历史(2016–2025)
EMERGENT BIOSOLUTIONS INC. (EBS) 年度经营现金流历史(来自 SEC 财报)—— 每个财年经营活动产生的现金净额。
$170.6MFY2025 · FY2016 以来:$54.6M → $170.6M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $170.6M | +190.6% |
| FY2024 | $58.7M | +128.5% |
| FY2023 | -$206.3M | -505.0% |
| FY2022 | -$34.1M | -110.6% |
| FY2021 | $320.2M | -40.4% |
| FY2020 | $536.9M | +185.6% |
| FY2019 | $188.0M | +349.8% |
| FY2018 | $41.8M | -79.9% |
| FY2017 | $208.1M | +281.1% |
| FY2016 | $54.6M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议